304 related articles for article (PubMed ID: 18511877)
21. Preoperative diagnosis of thyroid papillary and anaplastic carcinomas by real-time quantitative reverse transcription-polymerase chain reaction of oncofetal fibronectin messenger RNA.
Takano T; Miyauchi A; Yokozawa T; Matsuzuka F; Maeda I; Kuma K; Amino N
Cancer Res; 1999 Sep; 59(18):4542-5. PubMed ID: 10493503
[TBL] [Abstract][Full Text] [Related]
22. Cyclooxygenase 1 and 2 expressions in the human thyroid gland.
Lee HM; Baek SK; Kwon SY; Jung KY; Chae SW; Hwang SJ; Woo JS; Lee JY
Eur Arch Otorhinolaryngol; 2006 Mar; 263(3):199-204. PubMed ID: 16362262
[TBL] [Abstract][Full Text] [Related]
23. Expression profile of malignant and non-malignant diseases of the thyroid gland reveals altered expression of a common set of genes in goiter and papillary carcinomas.
Stolf BS; Abreu CM; Mahler-Araújo MB; Dellamano M; Martins WK; de Carvalho MB; Curado MP; Díaz JP; Fabri A; Brentani H; Carvalho AF; Soares FA; Kowalski LP; Hirata R; Reis LF
Cancer Lett; 2005 Sep; 227(1):59-73. PubMed ID: 16051032
[TBL] [Abstract][Full Text] [Related]
24. The helix-loop-helix protein, Id-1, is overexpressed and regulates growth in papillary thyroid cancer.
Kebebew E; Treseler PA; Duh QY; Clark OH
Surgery; 2003 Aug; 134(2):235-41. PubMed ID: 12947323
[TBL] [Abstract][Full Text] [Related]
25. Glypican-3 expression in primary and recurrent ovarian carcinomas.
Stadlmann S; Gueth U; Baumhoer D; Moch H; Terracciano L; Singer G
Int J Gynecol Pathol; 2007 Jul; 26(3):341-4. PubMed ID: 17581422
[TBL] [Abstract][Full Text] [Related]
26. Identification of immunohistochemical biomarkers for papillary thyroid carcinoma using gene expression profiling.
Murphy KM; Chen F; Clark DP
Hum Pathol; 2008 Mar; 39(3):420-6. PubMed ID: 18261626
[TBL] [Abstract][Full Text] [Related]
27. Distinction of hepatocellular carcinoma from benign hepatic mimickers using Glypican-3 and CD34 immunohistochemistry.
Coston WM; Loera S; Lau SK; Ishizawa S; Jiang Z; Wu CL; Yen Y; Weiss LM; Chu PG
Am J Surg Pathol; 2008 Mar; 32(3):433-44. PubMed ID: 18300806
[TBL] [Abstract][Full Text] [Related]
28. Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary.
Esheba GE; Pate LL; Longacre TA
Am J Surg Pathol; 2008 Apr; 32(4):600-7. PubMed ID: 18277882
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical analysis of the ras oncogene protein product in human thyroid neoplasms.
Papadimitriou K; Yiagnisis M; Tolis G; Spandidos DA
Anticancer Res; 1988; 8(6):1223-7. PubMed ID: 3064713
[TBL] [Abstract][Full Text] [Related]
30. Glypican-3 is expressed in chromophobe renal cell carcinomas.
Okoń K
Pol J Pathol; 2008; 59(1):15-20. PubMed ID: 18655366
[TBL] [Abstract][Full Text] [Related]
31. Loss of heterozygosity on chromosome 16p and 18q in anaplastic thyroid carcinoma.
Kadota M; Tamaki Y; Sekimoto M; Fujiwara Y; Aritake N; Hasegawa S; Kobayashi T; Ikeda T; Horii A; Monden M
Oncol Rep; 2003; 10(1):35-8. PubMed ID: 12469141
[TBL] [Abstract][Full Text] [Related]
32. Reduced expression of N-Myc downstream-regulated gene 2 in human thyroid cancer.
Zhao H; Zhang J; Lu J; He X; Chen C; Li X; Gong L; Bao G; Fu Q; Chen S; Lin W; Shi H; Ma J; Liu X; Ma Q; Yao L
BMC Cancer; 2008 Oct; 8():303. PubMed ID: 18940011
[TBL] [Abstract][Full Text] [Related]
33. Gene expression profiles in thyroid carcinomas.
Takano T; Hasegawa Y; Matsuzuka F; Miyauchi A; Yoshida H; Higashiyama T; Kuma K; Amino N
Br J Cancer; 2000 Dec; 83(11):1495-502. PubMed ID: 11076659
[TBL] [Abstract][Full Text] [Related]
34. Molecular profiling related to poor prognosis in thyroid carcinoma. Combining gene expression data and biological information.
Montero-Conde C; Martín-Campos JM; Lerma E; Gimenez G; Martínez-Guitarte JL; Combalía N; Montaner D; Matías-Guiu X; Dopazo J; de Leiva A; Robledo M; Mauricio D
Oncogene; 2008 Mar; 27(11):1554-61. PubMed ID: 17873908
[TBL] [Abstract][Full Text] [Related]
35. A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma.
Ngan ES; Lang BH; Liu T; Shum CK; So MT; Lau DK; Leon TY; Cherny SS; Tsai SY; Lo CY; Khoo US; Tam PK; Garcia-Barceló MM
J Natl Cancer Inst; 2009 Feb; 101(3):162-75. PubMed ID: 19176457
[TBL] [Abstract][Full Text] [Related]
36. Tie-1 tyrosine kinase expression in human thyroid neoplasms.
Ito Y; Yoshida H; Uruno T; Nakano K; Takamura Y; Miya A; Kobayashi K; Yokozawa T; Matsuzuka F; Kuma K; Miyauchi A
Histopathology; 2004 Apr; 44(4):318-22. PubMed ID: 15049896
[TBL] [Abstract][Full Text] [Related]
37. Expression of S100A2 and S100A6 in thyroid carcinomas.
Ito Y; Yoshida H; Tomoda C; Uruno T; Miya A; Kobayashi K; Matsuzuka F; Kakudo K; Kuma K; Miyauchi A
Histopathology; 2005 May; 46(5):569-75. PubMed ID: 15842639
[TBL] [Abstract][Full Text] [Related]
38. Expression of p57/Kip2 protein in normal and neoplastic thyroid tissues.
Ito Y; Yoshida H; Nakano K; Kobayashi K; Yokozawa T; Hirai K; Matsuzuka F; Matsuura N; Kuma K; Miyauchi A
Int J Mol Med; 2002 Apr; 9(4):373-6. PubMed ID: 11891530
[TBL] [Abstract][Full Text] [Related]
39. S100A10 expression in thyroid neoplasms originating from the follicular epithelium: contribution to the aggressive characteristic of anaplastic carcinoma.
Ito Y; Arai K; Nozawa R; Yoshida H; Higashiyama T; Takamura Y; Miya A; Kobayashi K; Kuma K; Miyauchi A
Anticancer Res; 2007; 27(4C):2679-83. PubMed ID: 17695432
[TBL] [Abstract][Full Text] [Related]
40. Glypican-3 immunocytochemistry in liver fine-needle aspirates : a novel stain to assist in the differentiation of benign and malignant liver lesions.
Kandil D; Leiman G; Allegretta M; Trotman W; Pantanowitz L; Goulart R; Evans M
Cancer; 2007 Oct; 111(5):316-22. PubMed ID: 17763368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
